UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
1. Name and Address of Reporting Person
Sample, Frank T.
P.O. Box 1070
1400 Shelburne Road
Burlington, VT 05402-1070
2. Date of Event Requiring Statement (Month/Day/Year)
7/10/97
3. I.R.S. Identification Number of Reporting Person, if an entity (Voluntary)
4. Issuer Name and Ticker or Trading Symbol
IDX Systems Corporation (IDXC)
5. Relationship of Reporting Person to Issuer (Check all applicable)
[X] Director [ ] 10% Owner
[X] Officer (give title below) [ ] Other (specify below)
Executive Vice President
and Director
6. If Amendment, Date of Original (Month/Day/Year)
07/18/97
7. Individual or Joint/Group Filing (Check Applicable Line)
[X] Form filed by One Reporting Person
[ ] Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
Table I Non-Derivative Securities Beneficially Owned
- -----------------------------------------------------------------------------------------------------
1)Title of Security 2)Amount of 3) 4)Nature of
Securities D Indirect
Beneficially or Beneficial
Owned I Ownership
- -----------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
Common Stock 36,830.00 (1) D Direct
Common Stock 4,099.00 I By 401(k) Plan
<CAPTION>
Table II Derivative Securitites Beneficially Owned
- ------------------------------------------------------------------------------------------------------------------------------------
1)Title of Derivative Security 2)Date Exercisable 3)Title and Amount of 4)Conver- 5)Ownership 6)Nature of
and Expiration Date Securities Underlying sion or Form of Indirect
(Month/Day/Year) Derivative Security exercise Derivative Beneficial
price of Security Ownership
Date Expira- Amount or Deri- Direct(D)
Exer- tion Number of vative or
cisable Date Title Shares Security Indirect(I)
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C>
Employee Stock Option (right to 07/10/97 01/23/02 Common Stock (4) 6,829.00 $5.7500 D Direct
buy) (2) (3)
Employee Stock Option (right to 07/10/97 12/03/00 Common Stock (4) 49,380.00 $5.8200 D Direct
buy) (2) (3)
Employee Stock Option (right to 07/10/97 02/03/04 Common Stock (4) 7,299.00 $6.5800 D Direct
buy) (2) (3)
Employee Stock Option (right to 07/10/97 01/30/07 Common Stock (4) 21,899.00 $20.7200 D Direct
buy) (2) (3)
Employee Stock Option (right to 07/10/97 01/27/05 Common Stock (4) 18,249.00 $23.1900 D Direct
buy) (2) (3)
Employee Stock Option (right to 07/10/97 01/25/06 Common Stock (4) 10,949.00 $32.8800 D Direct
buy) (2) (3)
<FN>
Explanation of Responses:
(1)
Pursuant to the terms of the Merger Agreement, all PHAMIS Common Stock and options for PHAMIS Common Stock were converted into .73
shares of IDX Common stock or options for IDX Common Stock (the 'Conversion Ratio'). For example, the reporting person owned 50,000
shares of PHAMIS Common Stock prior to the Effective Time of the Merger. After the conversion, the reporting person now owns
36,500 shares of IDX Common Stock (50,000 x .73 = 36,500)
(2)
Prior to the Effective Time of the Merger, the reporting person was a shareholder and optionee of PHAMIS and all of the reporting
person's PHAMIS Common Stock and options for PHAMIS Common Stock have been converted into IDX Common Stock and options for IDX
Common Stock.
(3)
Pursuant to the terms of the Agreement and Plan of Merger dated as of 3/25/97 (the 'Merger Agreement'), between PHAMIS, Inc.
('PHAMIS') and IDX Systems Corporation ('IDX'), all options became 100% vested and exercisable immediately prior the Merger. The
Effective Time of the Merger was July 10, 1997 and all options became exercisable as of that date.
(4)
Pursuant to the terms of the Merger Agreement, the purchase price per share of IDX Common Stock is determined by dividing the
purchase price per share of PHAMIS Common Stock subject to the PHAMIS option by the Conversion Ratio. For example, the reporting
person was granted options for PHAMIS stock on 01/25/96 at a purchase price of $24.00 ($24.00/.73 = $32.88)
</FN>
</TABLE>
SIGNATURE OF REPORTING PERSON
/S/ By: FRANK T. SAMPLE
For: DIANE L. BROWN, ATTORNEY-IN-FACT
DATE
